MRI Before TRUS Re-Biopsy Increases Accuracy
It seems intuitive, if not obvious, that superior imaging of the prostate gives precise information to guide a biopsy needle into a cancerous tumor. The typical ultrasound imaging used by urologists in their offices is inferior to magnetic resonance imaging (MRI). Ultrasound-guided transrectal (TRUS) biopsy has a minimum 35% chance of missing cancer. If our keep readingWould You Change Your Diet to Prevent PCa?
Do you know what causes cancer? Do you believe that diet can affect your chances of either causing or preventing prostate cancer? Would you change what you eat if you thought it could make a positive difference? I ran across an interesting small study that grew out of a larger British program called the ProDiet keep reading
How Do You Feel About Screening?
If you’re like most men age 40+, you probably get your PSA (prostate specific antigen) test when you go for a physical that includes a blood draw. You learned either from your doctor, or a health promotion, that men should get a baseline PSA at age 45 (40 if you have known risk factors) and keep reading
TRUS Biopsy: Still Trying to Solve the Riddle
Matt Mullenweg, the originator of the popular open source WordPress software, has been quoted as saying, “Whenever there’s a new form of media, we always think it’s going to replace the old thing, and it never does. We still have radio, however long after TV was introduced.” It can be just as true in medicine. keep reading
The PSA Controversy and the New York Times
The New York Times, like all news media, is a vehicle to air conflicting views. The November 25, 2014 issue ran a strongly-worded editorial opinion piece by Richard Ablin, PhD, the self-proclaimed “discoverer of PSA”... keep reading
From the RSNA: Poster on MRI and Anterior Prostate Cancer
For radiologists, no professional meeting is more exciting than the annual Radiological Society of North America (RSNA) meeting. Don’t let “North America” mislead you. This Chicago-based event opens on the Sunday after Thanksgiving and runs for six days. As the largest global medical conference, it draws tens of thousands of attendees from all over the keep readingFrom the RSNA: Poster on mpMRI and False Positive PCa
In case you missed my previous blog, I attended the Radiological Society of North American (RSNA) meeting in Chicago. Several poster presentations were devoted to multiparametric MRI of the prostate. In my last blog, I summarized a poster on mpMRI and imaging of the anterior zone of the prostate. This time, I’m reporting on another keep readingHemiablation vs. Focal Laser Ablation
When is a little treatment too much treatment? That curiosity was the foundation of a new study out of McGill University Health Center in Montreal.[i] The research team followed 157 patients who had been diagnosed with unilateral prostate cancer (cancer on one side of the gland only) and followed by repeat biopsy for a median keep reading
Statins and Prostate Cancer
As the song goes, “The hip bone is connected to the thigh bone…” but it fails to mention a unique relationship between the liver and the prostate. Although they are very different in their composition and function, they are indirectly connected by a blood-circulated fat, and a drug used to control its levels. The fat keep reading
